Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yarrow + moringa is a botanical combination derived from the extracts of *Achillea millefolium* (yarrow) and *Moringa oleifera* (moringa). This combination is primarily utilized in the dietary supplement and traditional medicine sectors for its purported anti-inflammatory, antioxidant, and digestive health benefits. Yarrow is traditionally recognized for its antispasmodic and diaphoretic properties, often attributed to its flavonoid and terpene content. Moringa, frequently referred to as the "miracle tree," is highly nutrient-dense and contains bioactive compounds such as isothiocyanates and polyphenols that exhibit significant free-radical scavenging activity and may modulate inflammatory cytokine production. The combination is typically marketed for general wellness, immune support, and metabolic health, though it is not recognized as a regulated pharmaceutical drug by major health authorities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yarrow + moringa.